Back to Markets
CLClimb Bio Inc

Climb Bio Inc

CLYMNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$10.96

-0.380000 (-3.35%)

As of 05/29/26 EDT · USD

Compare
Low: $1.16Current: $10.96High: $12.48

Key Statistics

Open

$11.24

Day High

$11.56

Day Low

$10.86

Prev. Close

$11.34

VolumeShares traded today.

585.82K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$627.58M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-14.13

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$12.48

52W LowLowest price over the past 52 weeks.

$1.16

50D MAAverage closing price over the last 50 trading days.

$9.14

200D MAAverage closing price over the last 200 trading days.

$4.88

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+0.5%

1M

+24.8%

6M

+508.9%

YTD

+192.3%

1Y

+828.8%

About

Yasuko Namba was the second Japanese woman to climb the Seven Summits. Namba worked as a businesswoman for FedEx in Japan, but her hobby of mountaineering took her all over the world. She first summited Kilimanjaro on New Year's Day in 1982, and summited Aconcagua exactly two years later. She reached the summit of Denali on July 1, 1985, and the summit of Mount Elbrus on August 1, 1992. After summiting Vinson Massif on December 29, 1993, and Carstensz Pyramid on November 12, 1994, Namba's final summit to reach was Mount Everest. She signed on with Rob Hall's guiding company, Adventure Consultants, and reached the summit in May 1996, but died during her descent in the 1996 Mount Everest disaster.

climbbio.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade CLYM

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.